Ahmed et al. (2016) investigated CRC cells that can resist radiotherapy via expression of FGFR4 and discovered that inhibiting FGFR4 can weaken the RAD51-mediated double strain break (DSB) repair, hence attenuating the anti-radiation effect. Here, RAD51 is linked to colorectal carcinoma.